Evidence map›Paper›PMID 33784177›Full record

ArticleJCO global oncology2021

Cancer Screening in the Coronavirus Pandemic Era: Adjusting to a New Situation.

Partha Basu, Samar Alhomoud, Katayoun Taghavi, Andre L Carvalho, Eric Lucas, Iacopo Baussano

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in JCO global oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04683744 (Facilitators and Barriers to Cancer Screening), which is not on this map. Cited by 33 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 3 pooled it
4.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04683744 completednot on this map

Facilitators and Barriers to Cancer Screening: Stakeholder Perspectives on Implementation

TypeobservationalSponsorIndiana UniversityRan2021 to 2023Enrolled82ConditionsColorectal Cancer ScreeningArmsSemi-structured interviews-Patients, Semi-structured interviews-Health system
3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 3 syntheses or guidelines pooled it, 50 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 3 countries.

Partha BasuInternational Agency for Research on Cancer, Lyon, France.ORCID 0000-0003-0124-4050
Samar AlhomoudSection Colorectal Surgery, King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia.
Katayoun TaghaviInstitute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.ORCID 0000-0003-0812-0069
Andre L CarvalhoInternational Agency for Research on Cancer, Lyon, France.
Eric LucasInternational Agency for Research on Cancer, Lyon, France.ORCID 0000-0002-1252-1925
Iacopo BaussanoInternational Agency for Research on Cancer, Lyon, France.
Centre international de recherche sur le cancer · FRKing Faisal Specialist Hospital & Research Centre · SAUniversity of Bern · CH

Funding

World Health Organization 001
6 · The paper itself

Abstract

purposeThe coronavirus-induced pandemic has put great pressure on health systems worldwide. Nonemergency health services, such as cancer screening, have been scaled down or withheld as a result of travel restrictions and resources being redirected to manage the pandemic. The present article discusses the challenges to cancer screening implementation in the pandemic environment, suggesting ways to optimize services for breast, cervical, and colorectal cancer screening.

methodsThe manuscript was drafted by a team of public health specialists with expertise in implementation and monitoring of cancer screening. A scoping review of literature revealed the lack of comprehensive guidance on continuation of cancer screening in the midst of waxing and waning of infection. The recommendations in the present article were based on the advisories issued by different health agencies and professional bodies and the authors' understanding of the best practices to maintain quality-assured cancer screening.

resultsA well-coordinated approach is required to ensure that essential health services such as cancer management are maintained and elective services are not threatened, especially because of resource constraints. In the context of cancer screening, a few changes in invitation strategies, screening and management protocols and program governance need to be considered to fit into the new normal situation. Restoring public trust in providing efficient and safe services should be one of the key mandates for screening program reorganization. This may be a good opportunity to introduce innovations (eg, telehealth) and consider de-implementing non-evidence-based practices. It is necessary to consider increased spending on primary health care and incorporating screening services in basic health package.

conclusionThe article provides guidance on reorganization of screening policies, governance, implementation, and program monitoring.

Indexed as

COVID-19Breast NeoplasmsColorectal NeoplasmsDelivery of Health CareEarly Detection of CancerFemaleHealth PolicyHumansMass ScreeningNeoplasmsPandemicsPractice Guidelines as TopicTelemedicineUterine Cervical Neoplasms

Identifiers

PMID33784177
PMCPMC8081552
OpenAlexW3145088349

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.